Interestingly, pharmacological activation of GPR55 in cholangiocarcinoma cells, however, diminishes cancer cell proliferation through activation of JNK pathway [174], which can be blocked by GPR55 knockdown, suggesting that GPR55 may also act as a tumor suppressor. Here, GPR55 is linked to cholangiocarcinoma.